2014
DOI: 10.1016/j.neuropharm.2014.06.019
|View full text |Cite
|
Sign up to set email alerts
|

The selective PAC1 receptor agonist maxadilan inhibits neurogenic vasodilation and edema formation in the mouse skin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(13 citation statements)
references
References 73 publications
(68 reference statements)
0
13
0
Order By: Relevance
“…This model is widely used to evaluate anti-inflammatory topical steroids and non-steroidal anti-inflammatory agents, especially those that inhibit phospholipase A2 ( Zanini et al, 1992 ; Núñez Guillén et al, 1997 ). In addition, several studies have shown that the xylene increases vascular permeability, which causes edema that indicates inflammation, due to the release of inflammatory agents such as bradykinin, prostaglandin, histamine and serotonin, which in turn release neuropeptides that activate their receptors, producing neurogenic inflammation ( Carlson et al, 1985 ; Banki et al, 2014 ). Substance P is one of these neuropeptides, which allows the release of nitric oxide from endothelial cells, triggering vasodilation and plasma exudation, which is the origin of edema formation ( Barry et al, 2011 ).…”
Section: Discussionmentioning
confidence: 99%
“…This model is widely used to evaluate anti-inflammatory topical steroids and non-steroidal anti-inflammatory agents, especially those that inhibit phospholipase A2 ( Zanini et al, 1992 ; Núñez Guillén et al, 1997 ). In addition, several studies have shown that the xylene increases vascular permeability, which causes edema that indicates inflammation, due to the release of inflammatory agents such as bradykinin, prostaglandin, histamine and serotonin, which in turn release neuropeptides that activate their receptors, producing neurogenic inflammation ( Carlson et al, 1985 ; Banki et al, 2014 ). Substance P is one of these neuropeptides, which allows the release of nitric oxide from endothelial cells, triggering vasodilation and plasma exudation, which is the origin of edema formation ( Barry et al, 2011 ).…”
Section: Discussionmentioning
confidence: 99%
“…And we first demonstrated PAC1R expression in hADSCs by gene testing and protein assay. In this study, it was revealed that maxadilan, a specific PAC1R agonist [28][29][30][31]54], could increase hADSC proliferation and promoted migration. It could also counteract hADSC apoptosis.…”
Section: Discussionmentioning
confidence: 83%
“…Maxadilan, isolated from the salivary glands of the sand fly Lutzomyia longipalpis, is a 61-amino acid vasodilatory peptide [28]. Although it has no prominent sequence homology with PACAP, maxadilan is a PAC1R-specific agonist and is used to assay the diverse physiological functions of PAC1R [29][30][31]. For example, maxadilan is used to determine that PAC1R activation prevents TNFmediated cell death in olfactory placode cells [22].…”
Section: Introductionmentioning
confidence: 99%
“…This stimulates not only the central nerves but also descends to the peripheral nerves, inducing the peptide from the sensory nerve terminal. It has been explained that as a result of the above process, the mast cells and the internal smooth muscles widen the blood vessels23 ) . The authors believe it to be necessary to start substantiating the study of these effects.…”
Section: Discussionmentioning
confidence: 99%